Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne E Tattersfield

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Medicine (London, England)|November 10, 2007
Advances in respiratory medicineAnne E Tattersfield
Clinical Reviews in Allergy & Immunology|November 7, 2006
Current issues with beta2-adrenoceptor agonists: historical backgroundAnne E Tattersfield
American Journal of Respiratory and Critical Care Medicine|December 22, 2005
Lymphangioleiomyomatosis: a national registry for a rare diseaseAnne E Tattersfield, Marilyn K Glassberg
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
LymphangioleiomyomatosisSimon R Johnson, Anne E Tattersfield
Immunology and Allergy Clinics of North America|August 2, 2005
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroidsKevin J Mortimer, Anne E Tattersfield
American Journal of Respiratory and Critical Care Medicine|February 24, 2006
beta-Adrenoceptor polymorphisms: focus moves to long-acting beta-agonistsAnne E Tattersfield, Timothy W Harrison
Lancet (London, England)|April 4, 2003
Low-dose budesonide for asthmaAnne E Tattersfield, Tim W Harrison
American Journal of Respiratory and Critical Care Medicine|March 29, 2003
Systemic effects of inhaled corticosteroidsTimothy W Harrison, Anne E Tattersfield
Drug Safety|September 8, 2004
A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary diseaseMilind P Sovani, Christopher I Whale, Anne E Tattersfield
Proceedings of the American Thoracic Society|August 23, 2005
Safety of inhaled corticosteroidsAnne E Tattersfield, T W Harrison, R B Hubbard, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Medicine (London, England)|November 10, 2007
Advances in respiratory medicineAnne E Tattersfield
Clinical Reviews in Allergy & Immunology|November 7, 2006
Current issues with beta2-adrenoceptor agonists: historical backgroundAnne E Tattersfield
American Journal of Respiratory and Critical Care Medicine|December 22, 2005
Lymphangioleiomyomatosis: a national registry for a rare diseaseAnne E Tattersfield, Marilyn K Glassberg
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
LymphangioleiomyomatosisSimon R Johnson, Anne E Tattersfield
Immunology and Allergy Clinics of North America|August 2, 2005
Benefit versus risk for oral, inhaled, and nasal glucocorticosteroidsKevin J Mortimer, Anne E Tattersfield
American Journal of Respiratory and Critical Care Medicine|February 24, 2006
beta-Adrenoceptor polymorphisms: focus moves to long-acting beta-agonistsAnne E Tattersfield, Timothy W Harrison
Lancet (London, England)|April 4, 2003
Low-dose budesonide for asthmaAnne E Tattersfield, Tim W Harrison
American Journal of Respiratory and Critical Care Medicine|March 29, 2003
Systemic effects of inhaled corticosteroidsTimothy W Harrison, Anne E Tattersfield
Drug Safety|September 8, 2004
A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary diseaseMilind P Sovani, Christopher I Whale, Anne E Tattersfield
Proceedings of the American Thoracic Society|August 23, 2005
Safety of inhaled corticosteroidsAnne E Tattersfield, T W Harrison, R B Hubbard, et al.
Pageof 3